(Q36705829)

English

Clinical proof-of-concept study with MSDC-0160, a prototype mTOT-modulating insulin sensitizer

scientific article published on 18 January 2013

Statements

Clinical proof-of-concept study with MSDC-0160, a prototype mTOT-modulating insulin sensitizer (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit